Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.14% Nasdaq Up0.86%

Boston Scientific Corporation (BSX)

-NYSE

7.27 0.00(0.00%) Apr 22, 4:00PM EDT|After Hours : 7.27 0.00 (0.00%) Apr 22, 4:42PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 7,249,000   7,622,000   7,806,000  
Cost of Revenue2,349,000  2,659,000  2,599,000  
Gross Profit 4,900,000   4,963,000   5,207,000  
Operating Expenses
Research Development886,000  895,000  939,000  
Selling General and Administrative2,529,000  2,494,000  2,582,000  
Non Recurring4,973,000  1,027,000  1,829,000  
Others395,000  421,000  513,000  
Total Operating Expenses8,783,000  4,837,000  5,863,000  
Operating Income or Loss (3,868,000) 904,000   (656,000)
Income from Continuing Operations
Total Other Income/Expenses Net37,000  797,000  (14,000)
Earnings Before Interest And Taxes(3,846,000)923,000  (670,000)
Interest Expense261,000  281,000  393,000  
Income Before Tax(4,107,000)642,000  (1,063,000)
Income Tax Expense(39,000)201,000  2,000  
Minority Interest -   -   -  
Net Income From Continuing Ops(4,068,000)441,000  (1,065,000)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (4,068,000) 441,000   (1,065,000)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (4,068,000) 441,000   (1,065,000)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.